Abstract
Antisense-mediated exon skipping has shown to be a promising therapeutic approach and is in clinical trials for Duchenne muscular dystrophy. However, after systemic treatment the majority of the injected antisense oligonucleotides (AONs) will not end up in the intended tissue. This mistargeting of AONs might have detrimental effects, especially with long-term treatment and continuous accumulation of AONs. Further, even when no detrimental effects occur, mistargeted AONs are lost for exon skipping in the intended tissue. One way to reduce the amount of mistargeted AONs is by adding a peptide that specifically binds to and is taken up by the intended tissue. Such peptides can be found by screening phage display libraries. With in silico, in vitro, and in vivo testing, the peptides that bind the intended tissue most efficiently and most specifically can be identified.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
van Deutekom JC, Janson AA, Ginjaar IB, Frankhuizen WS, Aartsma-Rus A, Bremmer-Bout M, den Dunnen JT, Koop K, van der Kooi AJ, Goemans NM, de Kimpe SJ, Ekhart PF, Venneker EH, Platenburg GJ, Verschuuren JJ, van Ommen GJ (2007) N Engl J Med 357:2677–2686
Kinali M, Arechavala-Gomeza V, Feng L, Cirak S, Hunt D, Adkin C, Guglieri M, Ashton E, Abbs S, Nihoyannopoulos P, Garralda ME, Rutherford M, McCulley C, Popplewell L, Graham IR, Dickson G, Wood MJ, Wells DJ, Wilton SD, Kole R, Straub V, Bushby K, Sewry C, Morgan JE, Muntoni F (2009) Lancet Neurol 8:918–928
Heemskerk HA, De Winter CL, de Kimpe SJ, Kuik-Romeijn P, Heuvelmans N, Platenburg GJ, van Ommen GJ, van Deutekom JC, Aartsma-Rus A (2009) J Gene Med 11:257–266
Heemskerk H, De Winter CL, van Ommen GJ, van Deutekom JC, Aartsma-Rus A (2009) Ann N Y Acad Sci 1175:71–79
Scott JK, Smith GP (1990) Science 249:386–390
Kehoe JW, Kay BK (2005) Chem Rev 105:4056–4072
Pasqualini R, Moeller BJ, Arap W (2010) Semin Thromb Hemost 36:343–351
Zhang L, Hoffman JA, Ruoslahti E (2005) Circulation 112:1601–1611
Kuzmicheva GA, Jayanna PK, Sorokulova IB, Petrenko VA (2009) Protein Eng Des Sel 22:9–18
Duchrow T, Shtatland T, Guettler D, Pivovarov M, Kramer S, Weissleder R (2009) BMC Bioinformatics 10:317
Huang J, Ru B, Li S, Lin H, Guo FB (2010) J Biomed Biotechnol 2010:101932
Brammer LA, Bolduc B, Kass JL, Felice KM, Noren CJ, Hall MF (2008) Anal Biochem 373:88–98
Di Niro R, Sulic AM, Mignone F, D’Angelo S, Bordoni R, Iacono M, Marzari R, Gaiotto T, Lavric M, Bradbury AR, Biancone L, Zevin-Sonkin D, De Bellis G, Santoro C, Sblattero D (2010) Nucleic Acids Res 38:e110
Dias-Neto E, Nunes DN, Giordano RJ, Sun J, Botz GH, Yang K, Setubal JC, Pasqualini R, Arap W (2009) PLoS One 4:e8338
’t Hoen PA, Jirka SM, Ten Broeke BR, Schultes EA, Aguilera B, Pang KH, Heemskerk H, Aartsma-Rus A, van Ommen GJ, den Dunnen JT (2012) Anal Biochem 421(2):622–631
Molenaar TJ, Michon I, de Haas SA, Van Berkel TJ, Kuiper J, Biessen EA (2002) Virology 293:182–191
Nicol CG, Denby L, Lopez-Franco O, Masson R, Halliday CA, Nicklin SA, Kritz A, Work LM, Baker AH (2009) FEBS Lett 583:2100–2107
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Heemskerk, H. (2012). Identification of Peptides for Tissue-Specific Delivery. In: Aartsma-Rus, A. (eds) Exon Skipping. Methods in Molecular Biology, vol 867. Humana Press. https://doi.org/10.1007/978-1-61779-767-5_24
Download citation
DOI: https://doi.org/10.1007/978-1-61779-767-5_24
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-766-8
Online ISBN: 978-1-61779-767-5
eBook Packages: Springer Protocols